Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 22
2008 22
2009 16
2010 21
2011 20
2012 23
2013 22
2014 29
2015 20
2016 15
2017 17
2018 13
2019 9
2020 10
2021 20
2022 7
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
Erythropoietin Stimulating Agents.
Schoener B, Borger J. Schoener B, et al. 2023 Mar 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2023 Mar 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 30725682 Free Books & Documents.
Erythropoietin (EPO) is a glycoprotein hormone, naturally produced by the peritubular cells of the kidney, that stimulates red blood cell production. ...Examples of ESAs are epoetin, darbepoetin, and methoxy polyethylene glycol-epoetin …
Erythropoietin (EPO) is a glycoprotein hormone, naturally produced by the peritubular cells of the kidney, that stimulates red blood …
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2014 Dec 8;2014(12):CD010590. doi: 10.1002/14651858.CD010590.pub2. Cochrane Database Syst Rev. 2014. PMID: 25486075 Free PMC article. Updated. Review.
SELECTION CRITERIA: Randomised controlled trials (RCTs) that included a comparison of an ESA (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene glycol-epoetin beta, or biosimilar ESA) with another ESA, place …
SELECTION CRITERIA: Randomised controlled trials (RCTs) that included a comparison of an ESA (epoetin alfa, epoetin beta …
Epoetin Beta.
[No authors listed] [No authors listed] 2021 Aug 16. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Aug 16. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30277694 Free Books & Documents. Review.
Methoxy polyethylene glycol-epoetin beta is a synthetic form of erythropoietin that slowly releases the active drug, epoetin beta (recombinant human erythropoietin). Erythropoietin is a normal component of huma …
Methoxy polyethylene glycol-epoetin beta is a synthetic form of erythropoietin that slowly release …
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.
Locatelli F, Hannedouche T, Fishbane S, Morgan Z, Oguey D, White WB. Locatelli F, et al. Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1701-1710. doi: 10.2215/CJN.01380219. Epub 2019 Aug 16. Clin J Am Soc Nephrol. 2019. PMID: 31420350 Free PMC article. Clinical Trial.
We compared cardiovascular outcomes and all-cause mortality associated with monthly methoxy polyethylene glycol-epoetin beta with those of the shorter-acting agents epoetin alfa/beta and darbepoetin alfa in patients with anemia of …
We compared cardiovascular outcomes and all-cause mortality associated with monthly methoxy polyethylene glycol-epoe …
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
Nangaku M, Hamano T, Akizawa T, Tsubakihara Y, Nagai R, Okuda N, Kurata K, Nagakubo T, Jones NP, Endo Y, Cobitz AR. Nangaku M, et al. Am J Nephrol. 2021;52(1):26-35. doi: 10.1159/000513103. Epub 2021 Feb 9. Am J Nephrol. 2021. PMID: 33561857 Free PMC article. Clinical Trial.
METHODS: Japanese patients not on dialysis (ND) (N = 299) with anemia of CKD (stages G3, G4, and G5) with iron parameters of ferritin >100 ng/mL or transferrin saturation >20% at screening were randomized to daprodustat or epoetin beta pegol (continuous …
METHODS: Japanese patients not on dialysis (ND) (N = 299) with anemia of CKD (stages G3, G4, and G5) with iron parameters of ferritin >10 …
Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.
Schmid H. Schmid H. Expert Rev Hematol. 2016 Jan;9(1):5-20. doi: 10.1586/17474086.2016.1112734. Epub 2015 Nov 17. Expert Rev Hematol. 2016. PMID: 26573694 Review.
Since more than two decades erythropoiesis-stimulating agents are the main pillar for treatment of anemia associated with chronic kidney disease. Methoxy polyethylene glycol-epoetin beta (MPG-EPO), also called continuous erythropoietin …
Since more than two decades erythropoiesis-stimulating agents are the main pillar for treatment of anemia associated with chronic kidney dis …
Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease.
Curran MP, McCormack PL. Curran MP, et al. Drugs. 2008;68(8):1139-56. doi: 10.2165/00003495-200868080-00009. Drugs. 2008. PMID: 18484803 Review.
Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin receptor activator, with a long half-life (approximately 130 hours). ...Methoxy polyethylene glycol-epoetin …
Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin recept …
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF. Chung EY, et al. Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3. Cochrane Database Syst Rev. 2023. PMID: 36791280 Review.
This is an update of a Cochrane review first published in 2014. OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene glycol-epoetin beta, and biosimilar E …
This is an update of a Cochrane review first published in 2014. OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, …
Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off?
Schmidt RJ. Schmidt RJ. Expert Opin Pharmacother. 2009 Jun;10(9):1509-14. doi: 10.1517/14656560902997982. Expert Opin Pharmacother. 2009. PMID: 19505218 Review.
As the use of these agents for chronic kidney disease (CKD) became widespread, the introduction of ESAs--touted for their longer-acting properties--was excitedly anticipated. OBJECTIVES: To review the option of methoxy polyethylene glycol-epoetin be …
As the use of these agents for chronic kidney disease (CKD) became widespread, the introduction of ESAs--touted for their longer-acting prop …
The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease.
Abood SJ, Abdulsahib WK, Al-Radeef MY. Abood SJ, et al. Heliyon. 2023 Feb 14;9(2):e13747. doi: 10.1016/j.heliyon.2023.e13747. eCollection 2023 Feb. Heliyon. 2023. PMID: 36865462 Free PMC article.
AIM: This research aimed to investigate the relation between resistance to the methoxy polyethylene glycol-epoetin beta (ME-beta) and angiotensin-converting enzyme (ACE) gene polymorphism. ...Comparing ACE polymorphism between good and hy …
AIM: This research aimed to investigate the relation between resistance to the methoxy polyethylene glycol-epoetin …
264 results